SageView Advisory Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-555
Closed -$75.6K 2476
2025
Q4
$75.6K Sell
555
-2,330
-81% -$335K ﹤0.01% 917
2025
Q3
$426K Buy
2,885
+8
+0.3% +$1.11K 0.01% 420
2025
Q2
$381K Buy
2,877
+126
+5% +$15.3K 0.01% 434
2025
Q1
$329K Sell
2,751
-39
-1% -$4.83K 0.01% 445
2024
Q4
$324K Buy
2,790
+98
+4% +$12.4K 0.01% 441
2024
Q3
$364K Buy
2,692
+27
+1% +$3.61K 0.02% 350
2024
Q2
$361K Buy
+2,665
New +$363K 0.02% 398
2024
Q1
Sell
-2,669
Closed -$304K 847
2023
Q4
$304K Buy
+2,669
New +$266K 0.01% 508

Other funds holding XYL

SageView Advisory Group's XYL Position: Q1 2026 in Review

SageView Advisory Group sold out of Xylem (XYL) in Q1 2026, closing a stake of 555 shares — an estimated $75.6K sold.

SageView Advisory Group first reported a position in XYL in Q4 2023 and held it in 8 quarters. The position peaked at $426K in Q3 2025. 1,114 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • SageView Advisory Group reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 555 Xylem shares in Q1 2026, an estimated $75.6K.
  • SageView Advisory Group first reported a position in Xylem in Q4 2023 and held it in 8 quarters.
  • SageView Advisory Group's Xylem position peaked at $426K in Q3 2025.
  • 1,114 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.